Several hospitals in the United States continue to use malaria drug hydroxychloroquine in the treatment of COVID-19 positive patients, a media report said. Medical publication, MDedge on Friday reported that hydroxychloroquine (HCQ), the malaria drug, is currently the first-line therapy and Tocilizumab the second-line medication for people hospitalized with polymerase chain reaction-confirmed COVID-19 infection in the Yale New Haven Health System, which operates hospitals across Connecticut.from IndiaTV: Google News Feed https://ift.tt/2YBEHej
Post a Comment